Material: Crystal

REIT Merger Tombstone

Custom financial tombstone commemorating the merger between Japanese real estate investment trusts Sakura Sogo and Star Asia.

(20AKL144)
1 Image

Custom Commemorative for Drug Licensing Agreement

Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau.

(20ALJ071)
1 Image

Jet-Themed Crystal Deal Toy

Crystal deal toy commemorating the acquisition by Japanese manufacturer Mitsubishi of the Canadair regional jet program of Canadian firm Bombardier.

(20AJH062)
2 Images
Custom crystal deal toy marking the sale to Mitsubishi of Canadair, Bombardier's regional jet program.

Pill-Themed Custom Crystal

Custom crystal marking construction of Our Medical Home North Lakes, located in Queensland’s Moreton Bay region. The facility is part of a network of medical centres operated by Australia’s Cornerstone Health.

(20AJH028)
1 Image

Custom Crystal for Series A Funding

Custom crystal celebrating Series A for Copenhagen-based podcast provider Podimo.

(20LJW11)
1 Image

ESPN Muhammad Ali Sports Humanitarian Award

Muhammad Ali Sports Humanitarian Award presented to Nelson Cruz of the Minnesota Twins at the 2020 ESPY’s.

(20AKL184)
1 Image

Credit Facilities Crystal Deal Toy

Crystal deal toy celebrating credit facilities provided for Australia’s National Broadband Network (NBN).

(20ALJ092)
2 Images
Crystal deal toy designed after a network termination device (NTD) offered by Australia's National Broadband Network. The device provides consumers with access to telephony and data channels.

Flag-Themed Pharmaceutical Deal Toy

Custom crystal deal toy commemorating the acquisition of Canada’s Dalton Pharma Services by Japanese pharmaceutical firm Seikagaku Corporation.

(20AMF085)
2 Images
Crystal deal toy marking a cross-border acquisition of Canadian Dalton Pharma Services. The acquirer was Seikagaku Corporation, an R&D-centered Japanese pharmaceutical firm.